India · Delayed Price · Currency is INR NSE:SUNPHARMA Statistics
Total Valuation
NSE:SUNPHARMA has a market cap or net worth of INR 4.16 trillion. The enterprise value is 3.93 trillion.
| Market Cap | 4.16T |
| Enterprise Value | 3.93T |
Important Dates
The last earnings date was Wednesday, November 5, 2025.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | Jul 7, 2025 |
Share Statistics
NSE:SUNPHARMA has 2.40 billion shares outstanding. The number of shares has increased by 0.11% in one year.
| Current Share Class | 2.40B |
| Shares Outstanding | 2.40B |
| Shares Change (YoY) | +0.11% |
| Shares Change (QoQ) | -0.01% |
| Owned by Insiders (%) | 12.01% |
| Owned by Institutions (%) | 29.35% |
| Float | 1.06B |
Valuation Ratios
The trailing PE ratio is 39.77 and the forward PE ratio is 34.64. NSE:SUNPHARMA's PEG ratio is 2.96.
| PE Ratio | 39.77 |
| Forward PE | 34.64 |
| PS Ratio | 7.56 |
| PB Ratio | 5.32 |
| P/TBV Ratio | 7.58 |
| P/FCF Ratio | 47.58 |
| P/OCF Ratio | 33.10 |
| PEG Ratio | 2.96 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 24.92, with an EV/FCF ratio of 45.02.
| EV / Earnings | 37.63 |
| EV / Sales | 7.15 |
| EV / EBITDA | 24.92 |
| EV / EBIT | 29.96 |
| EV / FCF | 45.02 |
Financial Position
The company has a current ratio of 2.57, with a Debt / Equity ratio of 0.07.
| Current Ratio | 2.57 |
| Quick Ratio | 1.85 |
| Debt / Equity | 0.07 |
| Debt / EBITDA | 0.33 |
| Debt / FCF | 0.60 |
| Interest Coverage | 47.79 |
Financial Efficiency
Return on equity (ROE) is 14.22% and return on invested capital (ROIC) is 10.59%.
| Return on Equity (ROE) | 14.22% |
| Return on Assets (ROA) | 8.57% |
| Return on Invested Capital (ROIC) | 10.59% |
| Return on Capital Employed (ROCE) | 16.39% |
| Revenue Per Employee | 12.78M |
| Profits Per Employee | 2.43M |
| Employee Count | 43,000 |
| Asset Turnover | 0.57 |
| Inventory Turnover | 1.18 |
Taxes
In the past 12 months, NSE:SUNPHARMA has paid 35.53 billion in taxes.
| Income Tax | 35.53B |
| Effective Tax Rate | 25.31% |
Stock Price Statistics
The stock price has decreased by -3.98% in the last 52 weeks. The beta is 0.27, so NSE:SUNPHARMA's price volatility has been lower than the market average.
| Beta (5Y) | 0.27 |
| 52-Week Price Change | -3.98% |
| 50-Day Moving Average | 1,650.18 |
| 200-Day Moving Average | 1,683.52 |
| Relative Strength Index (RSI) | 65.03 |
| Average Volume (20 Days) | 1,659,435 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:SUNPHARMA had revenue of INR 549.64 billion and earned 104.50 billion in profits. Earnings per share was 43.55.
| Revenue | 549.64B |
| Gross Profit | 429.78B |
| Operating Income | 131.57B |
| Pretax Income | 140.38B |
| Net Income | 104.50B |
| EBITDA | 156.68B |
| EBIT | 131.57B |
| Earnings Per Share (EPS) | 43.55 |
Balance Sheet
The company has 278.80 billion in cash and 52.15 billion in debt, giving a net cash position of 226.65 billion or 94.47 per share.
| Cash & Cash Equivalents | 278.80B |
| Total Debt | 52.15B |
| Net Cash | 226.65B |
| Net Cash Per Share | 94.47 |
| Equity (Book Value) | 781.27B |
| Book Value Per Share | 324.46 |
| Working Capital | 367.52B |
Cash Flow
In the last 12 months, operating cash flow was 125.54 billion and capital expenditures -38.20 billion, giving a free cash flow of 87.34 billion.
| Operating Cash Flow | 125.54B |
| Capital Expenditures | -38.20B |
| Free Cash Flow | 87.34B |
| FCF Per Share | 36.40 |
Margins
Gross margin is 78.19%, with operating and profit margins of 23.94% and 19.01%.
| Gross Margin | 78.19% |
| Operating Margin | 23.94% |
| Pretax Margin | 25.54% |
| Profit Margin | 19.01% |
| EBITDA Margin | 28.51% |
| EBIT Margin | 23.94% |
| FCF Margin | 15.89% |
Dividends & Yields
This stock pays an annual dividend of 16.00, which amounts to a dividend yield of 0.92%.
| Dividend Per Share | 16.00 |
| Dividend Yield | 0.92% |
| Dividend Growth (YoY) | 18.52% |
| Years of Dividend Growth | 6 |
| Payout Ratio | 35.73% |
| Buyback Yield | -0.11% |
| Shareholder Yield | 0.82% |
| Earnings Yield | 2.51% |
| FCF Yield | 2.10% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 29, 2013. It was a forward split with a ratio of 2.
| Last Split Date | Jul 29, 2013 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |